http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36330273

Outgoing Links

Predicate Object
contentType Journal Article
issn 0720-048X
pageRange 111050-
publicationName European Journal of Radiology
startingPage 111050
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Liu J, Zhang Z, Bian H, Zhang Y, Ma W, Wang Z, Yin G, Dai D, Chen W, Zhu L, Xu W, Zhang H, Li X. Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results. European Journal of Radiology. 2023 Oct;167():111050. doi: 10.1016/j.ejrad.2023.111050.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d6165a671c527deaa054debe8c6e7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1837477c1cad7b292809c79733830b14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53d5309cfe721164bdea61488499528b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fb6bc5811012ec123c726630abad1fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f7bddcb5b2a4ac4d1b5452f20ab9e18
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c532ad1c87df2a5841b0ed9700f9e987
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdfb1751f9e34381c8a87fb973b344bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70b36ae81f745c81587e35a80388886c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22aeb3145158cc5c61c50ac54d96e8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e28a67a69f202fae1d6154887dad3058
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afb2d650bcdce3e107d3119f7b95d57e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4a85484619fe0fb66fcb0ccc354814d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_480eba83451d28de1741a039badd37fd
date 202310
identifier https://doi.org/10.1016/j.ejrad.2023.111050
https://pubmed.ncbi.nlm.nih.gov/37598640
isPartOf https://portal.issn.org/resource/ISSN/0720-048X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3584
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results
discusses http://id.nlm.nih.gov/mesh/M0029360
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000000981
http://id.nlm.nih.gov/mesh/D000072078Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019788
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D012189
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a81b4e81fe71a07613c76a5538fe8b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf22a1d0acfca4af517e1417a80e92d1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3232583

Showing number of triples: 1 to 43 of 43.